Protocol ICAC-30 Mechanisms Underlying Asthma Exacerbations Prevented and Persistent with Immune-Based Therapy: A Systems Approach Phase 2
MUPPITS-2: Study of Asthma Medication in Children with Asthma
Sponsor: NIAID
Enrolling: Male and Female Patients
IRB Number: AAAR4384
U.S. Govt. ID: NCT03292588
Contact: Marcela Pierce: 347-344-3000 / mp2648@cumc.columbia.edu
Additional Study Information: Research funded by the NIH is being done to learn if an asthma medication, given along with standard asthma care, makes children less likely to have asthma attacks.
This study is closed
Investigator
Meyer Kattan, MD
Do You Qualify?
Is your child between 6 and 18 years of age? Yes No
Does your child have asthma? Yes No
Has your child had 2 or more asthma attacks in the last year? Yes No
Does your child take asthma medication daily? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Marcela Pierce
mp2648@cumc.columbia.edu
347-344-3000
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE